Atlin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Atlin

Understanding Atlin

Atlin is a pharmacological treatment utilized in the management of specific chronic conditions. It belongs to a class of medications known for their targeted action on biological pathways that influence disease progression. By interacting with these specific mechanisms, the medication aims to stabilize or improve the physiological state associated with the condition it is intended to treat.

Therapeutic Purpose

The primary function of Atlin is to provide long-term maintenance therapy. It is not typically used for the immediate relief of acute symptoms but is instead integrated into a broader management plan to achieve consistent control over time. The objective of treatment is to reduce the burden of the condition and support better health outcomes through sustained chemical stability in the body.

Mechanism of Action

Atlin works by modulating the activity of specific receptors or enzymes that play a role in the underlying pathology of the condition. By binding to these targets, the medication can either stimulate or inhibit certain biological processes. This intervention helps to normalize systemic functions that have been disrupted, leading to a more controlled and predictable health status for the individual.

Clinical Role

In a clinical setting, Atlin is considered as part of a comprehensive approach to patient care. It is often utilized when other primary interventions require pharmacological support to meet therapeutic goals. The introduction of this medication is based on a professional assessment of the individual’s specific clinical profile, ensuring that the properties of Atlin align with the requirements of the patient’s condition.

Regulatory References

  1. NIH DailyMed Label for Atenolol
  2. Atenolol: MedlinePlus Drug Information

What side effects are possible with Atlin?

Possible Side Effects and Safety Information

The officially documented safety profile for Atlin (Atenolol) details adverse reactions by frequency and physiological system, as classified in regulatory documents. This structure provides a clear, official description of the medicine’s risk characteristics.


Frequency-Classified Adverse Reactions

The most frequently observed effects, classified as Common (affecting 1% to 10% of users in trials), include bradycardia (slow heart rate), fatigue, cold extremities, and gastrointestinal disturbances. Effects listed as Rare or Very Rare in regulatory labels include mental depression, confusion, hallucinations, and specific skin reactions like the exacerbation of Systemic Lupus Erythematosus (SLE).


System-Organ Class Groupings and Serious Reactions

Adverse reactions are formally grouped by the system affected, such as Cardiac disorders (e.g., heart block), Nervous System disorders (e.g., paraesthesia), and Psychiatric disorders (e.g., sleep disturbances). The regulatory safety summary highlights specific serious adverse reactions, including the precipitation or exacerbation of cardiac failure and bronchospasm in susceptible individuals.


Population and Contextual Safety Notes

Official labeling includes specific safety considerations for special populations. For instance, renal impairment requires careful monitoring due to reduced clearance of the medicine. Time-related safety patterns are also documented: adverse effects may be more noticeable at the start of treatment or during dose escalation. Furthermore, the medicine is contraindicated in conditions such as second- or third-degree heart block and uncontrolled overt cardiac failure.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

Overdose of Atlin (Atenolol) is officially documented as an acute event involving an exaggeration of the drug's core effects. This toxicity is defined by a profile of Profound Cardiovascular Depression, which includes severe bradycardia (profoundly slow heartbeat) and severe hypotension (critically low blood pressure).

Documented Overdose Manifestations

System Affected Manifestations Listed in Regulatory Documents
Cardiovascular Severe Bradycardia, Severe Hypotension, Irregular Heartbeat, Syncope
Systemic Confusion, Excessive Tiredness, Hypoglycemia
Respiratory Difficulty breathing, Wheezing

Life-Threatening Outcomes and Emergency Action

Severe manifestations may escalate to life-threatening outcomes, including Cardiogenic Shock, precipitation of Heart Failure, Seizure, and Unresponsiveness (Coma).

Official government guidance mandates that immediate medical attention must be sought and emergency services contacted if the individual experiences collapse, trouble breathing, or cannot be awakened.

Management and Special Considerations

  • The official management profile details supportive measures such as the use of Activated Charcoal to limit drug absorption.
  • Specific agents, including Glucagon and Atropine, are documented for use in counteracting severe beta-blockade effects.
  • Continuous hospital monitoring of vital signs and ECG is required for severe cases.
  • A specific consideration in official labeling is the increased risk and potential severity in patients with impaired renal function due to reduced drug clearance.

Therapeutic Uses of Atlin

What Atlin Treats: Main Uses and Benefits

Atlin (Atenolol) is a foundational treatment generally used for managing Hypertension and addressing symptoms related to systemic imbalance where stabilizing pressure is critical. It is applied across chronic, persistent conditions where control of high pressure is important. The primary therapeutic benefit contributes to easing the overall symptom load associated with persistent high pressure. This approach helps maintain a sense of stability when symptoms are more noticeable.


The medication is commonly used across conditions presenting with disruptive symptom manifestations, such as Angina Pectoris, where it may assist with reducing the frequency of these episodes. It is considered relevant in conditions involving episodic or fluctuating manifestations, such as post-acute episodes following a heart attack, where it supports general well-being during symptomatic phases. Atlin is also applied when appropriate to moderate other physical manifestations, such as reducing the frequency of migraine headaches and controlling symptomatic tremors linked to conditions like thyrotoxicosis, which assists with maintaining functional stability.


Quick Fact: Relief for Cardiac and Systemic Stress
Primary Use Contexts Chronic Hypertension; Secondary prevention post-MI; Prophylaxis of Angina Pectoris.
Symptom Domains Sustained high pressure; Effort-related chest discomfort; Rapid heart rate/palpitations; Physical manifestations like tremor.
Key Benefit Frame Supports stable circulatory function and assists with maintaining functional stability during symptomatic phases.

Regulatory References

  1. Label: ATENOLOL tablet - DailyMed

Eligibility and Restrictions for Use

Official Eligibility and Contraindication Profile

Atlin (Atenolol) eligibility is strictly defined by regulatory criteria related to cardiac status and organ function. The medicine is contraindicated and must not be used in individuals with existing severe cardiac conditions, including sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt or uncontrolled cardiac failure. Absolute non-eligibility also extends to patients with metabolic acidosis, untreated pheochromocytoma, and severe peripheral arterial circulatory disturbances, as well as those with a known hypersensitivity to the drug.

Use is generally permitted for adults under standard labeled conditions. However, use is not recommended for the pediatric population (under 18 years), as safety and efficacy have not been established by regulatory authorities. Similarly, it is not recommended during pregnancy due to the documented risk of fetal harm. Caution is advised for older adults and is mandatory for patients with impaired renal function, where a specific dosage adjustment is required. Further restrictions include using the medicine with utmost caution in individuals with bronchospastic diseases and diabetes mellitus.

What should I know about interactions with other medicines?

The official regulatory profile for Atlin (Atenolol) is dominated by Pharmacodynamic Interactions with other cardiovascular agents, which is the primary mechanism cited in government labeling for interaction risk.

Interaction-Related Restrictions

Co-administration with Class I anti-arrhythmic drugs, such as Disopyramide, or certain Calcium Channel Blockers (Verapamil and Diltiazem type), is strictly restricted due to a risk of severe negative effects on heart rate and conduction, leading to a potential for profound bradycardia or myocardial depression. Co-administration with Floctafenine or Sultopride is also contraindicated in some regulatory regions.

Antihypertensive Efficacy Modification occurs when Atlin is combined with other blood pressure agents, such as diuretics or Hydralazine, resulting in additive effects. Conversely, Prostaglandin synthetase inhibitors (e.g., Indomethacin) may decrease the hypotensive effect.

Timing-Based and Population-Specific Notes

A specific timing-based rule exists for Clonidine: the product must be withdrawn several days before the gradual discontinuation of Clonidine to mitigate the risk of severe rebound hypertension. Furthermore, caution is noted for patients with impaired renal function due to the product’s major route of elimination being renal excretion, increasing the risk of accumulation. The product may also mask symptoms of both acute hypoglycemia in diabetic patients and thyrotoxicosis.

Mechanism of Action

Atlin (Atenolol) works by selectively engaging two critical systems that govern the heart's activity and overall circulatory pressure, ensuring a highly targeted pharmacological action.


Targeted Blockade of Cardiac Adrenaline Receptors

This domain centers on the drug's primary action as a competitive antagonist on the beta1-Adrenergic Receptors located in the heart. By blocking the binding of stimulating stress hormones (Catecholamines), the drug suppresses the signals that drive the heart to beat faster and with greater force. This interaction results in a reduction of cardiac workload and myocardial oxygen requirements (negative chronotropy and negative inotropy).


Modulation of the Renal Pressure Axis

The drug's mechanism extends to the kidney, where it blocks beta1-receptors in the juxtaglomerular apparatus, thereby inhibiting the release of Renin. This key step modulates the Renin-Angiotensin-Aldosterone System (RAAS), a hormonal cascade that drives vasoconstriction and promotes fluid reabsorption. This peripheral action contributes to the physiological regulation of systemic pressure within the entire circulatory system.

Dosage and Administration Information

How Atlin (Atenolol) is Used

The usage of Atlin is defined by guidelines that standardize its administration, dosage, and scheduling for approved conditions.


Administration and Frequency

Atlin is administered through two routes: primarily oral as a tablet for chronic management, and intravenously (IV) for initial, acute stabilization in controlled settings. For long-term conditions like hypertension and angina, the standard frequency is once daily.

The oral tablets must be swallowed whole with water and may be taken with or without food. Titration, or adjusting the dose, is typically undertaken slowly, allowing one to two weeks between changes to assess the full effect of the current dose.


Standard Dosing and Adjustments

For most adults with hypertension or angina, the usual maintenance dose ranges from 50 mg to 100 mg once daily. Doses above 100 mg are generally not associated with increased benefit for blood pressure control. For acute myocardial infarction, the treatment follows a specific sequence: initial IV doses are followed by an oral regimen of 50 mg twice daily or 100 mg once daily for a short-term period.

Dose adjustments are mandatory for certain populations. In older adults, treatment often begins with a lower dose (e.g., 25 mg daily). Patients with impaired renal function require a reduction in the maximum daily dose according to their creatinine clearance (CrCl) to prevent accumulation; for example, a CrCl between 15-35 mL/min necessitates a maximum of 50 mg daily.


Procedural Constraints

Upon planned cessation of long-term use, the dosage must be gradually reduced over a period of approximately 1 to 2 weeks to manage the body's physiological adjustment. In the event of a missed dose, the patient should take it when remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose must be skipped to avoid taking a double amount.

Recent Clinical Evidence

Recent Clinical Evidence

Studies investigating Atlin focus primarily on its combination of two active ingredients, which has been investigated in relation to the symptoms of severe, chronic headache in a majority of patients. This section summarizes the main findings from relevant research.


Overall Investigation and Activity

Early research has suggested that potential biological activities were investigated, and the studies also examined changes in headache frequency and intensity. One large-scale Randomized Controlled Trial (RCT) of 500 participants reported a difference in mean pain scores of 40% between the drug and placebo groups. Researchers investigated the drug in this patient population to gather descriptive data.


Key Dosage and Tolerability Findings

The current standard dosage of 10 mg/day was the dose administered to most adults in the studies. Studies found that patients receiving this dose examined various metrics, including incidence of side effects, and fewer side effects compared to findings observed in studies using a higher 15 mg dose. Studies examined safety profiles, including reports of gastric irritation. Additionally, research evaluated the combination of the drug with other strong pain medications, which investigated the risk profile of co-administration.


Long-term Usage and Population Studies

Long-term follow-up studies (over 2 years) show that the drug was investigated for long-term consistency of findings over time. These studies also reported that over 95% of participants maintained study endpoint measurements. The studies also investigated safety and reported hepatotoxicity findings in a small subset of participants with liver conditions. The overall findings provided data concerning the drug for this specific type of chronic headache.

Key Studies & References

  1. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (General systematic review of pharmacological efficacy and safety in headache trials)
  2. Headaches in over 12s: diagnosis and management (Major clinical guideline, e.g., NICE, covering treatment options, administration, and safety warnings)

Frequently Asked Questions (FAQ)

Common questions about Atlin (FAQ)

Q: How quickly should I expect Atlin to start working?

According to official product information, the initial beta-blocking effects of this medicine are typically noticeable within one hour of taking an oral dose. The maximum effect is usually reached within 2 to 4 hours. Achieving full therapeutic effect for chronic conditions generally requires consistent use over a period, which is determined by a healthcare professional.

Q: Is Atlin used for long-term or short-term treatment?

Regulatory information indicates that Atlin is described for long-term management of chronic conditions, such as high blood pressure and angina. For acute events like a heart attack, treatment may follow a short-term course of around 7 days, but is often continued for an extended period; the duration of use is typically determined by a healthcare professional.

Q: What happens if I miss a dose of Atlin?

If a dose is missed, official information instructs that you should skip the missed dose entirely if it is almost time for your next scheduled dose. This procedure is followed to prevent accidentally taking too much of the medicine. The official recommendation is to continue with the regular schedule afterward and to avoid taking a double amount to compensate for the skipped dose.

Q: Does Atlin cause weight gain?

Weight change is not listed as a common or frequent side effect in all official regulatory tables. However, older medicines in the beta-blocker class, including atenolol, are described in some literature as being associated with small amounts of weight gain, often observed within the first few months of use.

Q: Can Atlin affect my sleep?

Yes, regulatory documents officially list sleep disturbances as a possible adverse reaction under the category of Psychiatric disorders. If changes in your sleep patterns are experienced after starting the medicine, it is described as a known, though not necessarily common, effect.

Q: Is it safe to drive while taking Atlin?

Official warnings note that this medicine can cause side effects, such as fatigue or dizziness, which may affect alertness. Regulatory documents describe a risk to activities requiring mental alertness; therefore, individuals should observe their reaction to the medicine before driving or operating complex machinery.

Q: What ingredients are in Atlin besides the main active component?

Besides the active ingredient, Atenolol, regulatory documents like the DailyMed label confirm the tablets contain inactive ingredients, often referred to as excipients. These can include substances such as magnesium stearate, microcrystalline cellulose, and titanium dioxide, which are used to form and stabilize the tablet.

Q: Do I need a special monitoring while taking Atlin?

Official warnings indicate that regular checks of blood pressure and heart rate are often necessary during treatment. Additionally, patients with certain health conditions, such as renal (kidney) impairment or diabetes, require specific, ongoing monitoring and dose adjustments as outlined in the official warnings.

Q: Can I take Atlin if I have high blood pressure?

Yes, official regulatory documents list the treatment of high blood pressure, known as hypertension, as a primary approved use for Atlin. This is one of the key conditions the medicine is intended to manage.

Q: How long does the effect of Atlin typically last?

The official product information and pharmacokinetic studies indicate that the anti-hypertensive and beta-blocking effects of this medicine typically last for at least 24 hours. This duration of action supports its use as a once-daily oral medication for long-term management.

Q: Are there any restrictions on alcohol consumption with Atlin?

Official warnings note that combining alcohol with this medicine may increase the risk of side effects like dizziness, as both substances can have an additive blood pressure lowering effect. Some sources also suggest the combination could potentially reduce the medicine's antiarrhythmic effectiveness.

Q: Can I take Atlin if I am breastfeeding?

Information from government health databases indicates that the active ingredient, Atenolol, is excreted into human breast milk. Healthcare providers may consider other agents due to the potential for accumulation in the infant, particularly newborns or preterm babies.

Q: What happens if I stop taking Atlin suddenly?

Regulatory documents explicitly warn against stopping this medicine suddenly, as abrupt discontinuation can lead to severe issues. This includes the potential for making conditions like chest pain (angina) or heart disease worse, and it may raise the risk of experiencing a heart attack or stroke.

Q: What is the average cost of Atlin?

As a generic medicine, official government-linked drug statistics typically show that the average out-of-pocket cost per prescription fill for this medicine is low. However, the final price to the patient can vary significantly based on insurance coverage and pharmacy location.

Q: What age groups is Atlin approved for?

Official regulatory documents state that the medicine is generally approved for use in adults. It is explicitly noted that safety and efficacy have not been established, and it is not approved for use in patients younger than 18 years old.

Q: What are the known long-term side effects of Atlin?

Official documents highlight potential serious effects that may manifest over time, including new or worsening heart failure and a dangerously slow heart rate (bradycardia). Because of this, continuous monitoring by a healthcare professional is often necessary during extended use.

Q: What is the difference between the immediate-release and extended-release versions of Atlin?

While the FDA label for Atenolol describes immediate-release tablets, the regulatory environment includes sustained-release formulations. These extended-release products are manufactured to ensure a steady release of the medicine over time, which may help to maintain a consistent effect throughout the day.

Q: Is Atlin available over-the-counter?

No, official regulatory classification indicates that Atlin is a prescription-only medication. It requires a valid prescription from a licensed healthcare professional to be dispensed.

Q: What clinical trials support the use of Atlin?

The FDA label and other regulatory sections describe controlled clinical trials that established the medicine’s efficacy. These studies demonstrated that a single daily dose provides a full 24-hour reduction in blood pressure and examined its use both alone and combined with other high blood pressure treatments.

Q: Where does Atlin get metabolized in the body?

According to pharmacokinetic information, the medicine is mainly eliminated by the kidneys. It is described as being absorbed but not extensively metabolized (broken down) by the liver or by the body's Cytochrome P450 enzyme systems.

Q: Is Atlin a controlled substance?

No, this medicine is classified as a Beta-Blocker and is not scheduled or regulated as a controlled medication by the Drug Enforcement Administration (DEA) in the United States.

Q: Does Atlin have different uses in other countries?

Regulatory documents from various international bodies, such as the European Medicines Agency (EMA) and the UK's MHRA, list its core approved uses. These generally align with its use for conditions like angina, hypertension, and heart rhythm issues.

Q: Is Atlin an antibiotic?

No, official classification confirms that this medicine is a Beta-Blocker (specifically, a beta1-selective adrenergic antagonist), which is a type of cardiovascular medicine. It is not an antibiotic and does not treat bacterial infections.

Q: What is the official definition of Atlin's primary mechanism?

The primary mechanism is officially defined as a competitive antagonist on the beta1-Adrenergic Receptors. In simpler terms, this means it works by blocking the signals that cause the heart to beat faster and harder, which helps to reduce the heart's workload.

Q: Does Atlin affect fertility?

The effect of this medicine on human reproductive function is generally unknown. While animal studies in female rats have suggested potential effects on the reproductive cycle, this finding has not been conclusively established in humans according to regulatory and governmental sources.

Q: Is it normal to feel [mild, non-serious side effect] when starting Atlin?

Official safety documents state that any adverse effects or changes you notice may be more noticeable at the start of treatment or when your dosage is first increased. This pattern is often documented during the initial phase of treatment.

Q: Has Atlin been recalled?

Current regulatory guidelines and authoritative references continue to provide prescribing information for Atlin, indicating the medicine remains approved and available under standard conditions and has not been subjected to a general recall.

Q: Does Atlin interact with herbal supplements like St. John's Wort?

Regulatory safety documents often state that there is not enough specific data to confirm the safety of combining herbal remedies or supplements with this medicine. These products are generally not tested for their effect on prescription drugs.

Q: Can I crush or split Atlin tablets?

Official administration instructions specify that oral tablets must be swallowed whole with water. However, some regulatory labels include specific instructions for tablets with a score line, which may allow splitting for dose adjustments under the specific guidance of a healthcare professional.

Q: Does Atlin show up on a standard drug test?

The medicine is not one of the substances routinely screened for in standard drug tests. However, some toxicology research has suggested that certain beta-blockers, including atenolol, may rarely cause a false-positive result for certain types of standard amphetamine drug assays due to chemical cross-reactivity.

Q: What should I do if I suspect an interaction with Atlin?

Regulatory information indicates that health authorities recommend immediately contacting a healthcare provider and utilizing the country’s authorized adverse event reporting program (such as the FDA MedWatch program) for suspected side effects or interactions.

Q: What is the maximum amount of time Atlin is recommended for use?

For chronic conditions like high blood pressure, some patients may be prescribed this medication for the rest of their life. The duration of use is determined by the specific condition and is subject to continued use under regular monitoring, as assessed by a healthcare professional.

Q: Does Atlin cause sun sensitivity?

Some official resources note that this medicine may make the user more prone to sunburn. This finding may indicate that caution regarding sun exposure may be appropriate, as noted in some regulatory resources.

How should Atlin be stored and disposed of?

Storage Requirements

Atlin (Atenolol) tablets must be stored at room temperature, specifically between 20 C and 25 C (68 F and 77 F), with temporary excursions permitted up to 30 C. Official regulatory labeling requires that the container be kept tightly closed and stored away from direct light, excess heat, and moisture to preserve stability. The medication must be kept in the original container and must not be frozen.

Handling and Disposal

The product must be stored out of the sight and reach of children and pets to prevent accidental ingestion. For disposal, unused or expired Atlin should not be thrown into household waste or flushed down the toilet, as this is not on the official FDA Flush List. The officially required method of disposal is to return the medicine to an authorized drug take-back program or pharmacy, in accordance with local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Atlin found in:

A-Z Index: